Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07532031Not Yet Recruiting

APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas

Role: collaborator

NCT06300125Recruiting

Percutaneous Cryoablation of Low-risk Early Breast Cancer

Role: collaborator

NCT06922266Not Yet Recruiting

Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option

Role: collaborator

NCT01948661Not ApplicableCompleted

Anthocyanin Extract and Phospholipid Curcumin in Colorectal Adenoma

Role: collaborator

NCT06284343Recruiting

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Role: collaborator

NCT03284008Not ApplicableCompleted

Assessing Efficacy of Axillary Web Syndrome Treatment

Role: collaborator

NCT02804893Not ApplicableUnknown

Videothoracoscopic (VATS) vs. Robotic Approach for Lobectomy or Anatomical Segmentectomy

Role: collaborator

NCT02422914Not ApplicableUnknown

Benefits of Tobacco Free Cigarette

Role: collaborator

All 8 trials loaded